Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) has been given an average recommendation of “Hold” by the twenty brokerages that are presently covering the stock, MarketBeat Ratings reports. Fourteen equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $11.81.
A number of brokerages recently weighed in on TDOC. Stifel Nicolaus lowered their target price on shares of Teladoc Health from $16.00 to $9.00 and set a “hold” rating on the stock in a research note on Thursday, August 1st. Canaccord Genuity Group reduced their price objective on Teladoc Health from $25.00 to $17.00 and set a “buy” rating on the stock in a research report on Thursday, August 1st. Truist Financial cut their target price on Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a research note on Friday, August 2nd. DA Davidson dropped their target price on Teladoc Health from $12.00 to $8.00 and set a “neutral” rating for the company in a report on Thursday, August 1st. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $10.00 price objective on shares of Teladoc Health in a research note on Tuesday, August 20th.
Read Our Latest Stock Analysis on TDOC
Insider Buying and Selling
Institutional Trading of Teladoc Health
Institutional investors have recently made changes to their positions in the stock. Rubric Capital Management LP bought a new stake in shares of Teladoc Health during the 2nd quarter valued at about $45,267,000. Point72 Asset Management L.P. grew its position in shares of Teladoc Health by 221.9% during the 2nd quarter. Point72 Asset Management L.P. now owns 5,303,123 shares of the health services provider’s stock valued at $51,865,000 after acquiring an additional 3,655,436 shares during the period. Clearline Capital LP increased its stake in shares of Teladoc Health by 395.6% in the 2nd quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock worth $42,682,000 after purchasing an additional 3,483,665 shares in the last quarter. Vanguard Group Inc. raised its holdings in Teladoc Health by 11.8% in the 4th quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock worth $377,451,000 after purchasing an additional 1,855,480 shares during the period. Finally, Assenagon Asset Management S.A. purchased a new position in Teladoc Health during the third quarter valued at $15,801,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.
Teladoc Health Stock Down 0.3 %
TDOC stock opened at $8.58 on Friday. Teladoc Health has a twelve month low of $6.76 and a twelve month high of $22.54. The firm has a market capitalization of $1.45 billion, a PE ratio of -6.08 and a beta of 0.91. The company has a quick ratio of 1.62, a current ratio of 1.66 and a debt-to-equity ratio of 0.66. The stock has a 50-day simple moving average of $8.30 and a two-hundred day simple moving average of $9.87.
Teladoc Health (NYSE:TDOC – Get Free Report) last posted its earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.36) by $0.08. The business had revenue of $642.44 million for the quarter, compared to analysts’ expectations of $649.34 million. Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%. On average, equities analysts predict that Teladoc Health will post -1.18 EPS for the current fiscal year.
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Stories
- Five stocks we like better than Teladoc Health
- What is MarketRankā¢? How to Use it
- Texas Roadhouse Stock Steering for New Highs This Year
- 3 Warren Buffett Stocks to Buy Now
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- The How And Why of Investing in Oil Stocks
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.